Nandakumar Narayanan
University of Iowa
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nandakumar Narayanan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:01 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07288450 · Terazosin And Metabolic Engagement in Parkinson's DiseaseNandakumar Narayanan · withdrawn · Parkinson's Disease · principal investigator
- Ph1/Ph2NCT04760860 · Terazosin for Dementia With Lewy BodiesQiang Zhang · not yet recruiting · Dementia With Lewy Bodies · principal investigator
- Ph1/Ph2NCT03905811 · A Pilot Study of Terazosin for Parkinson's DiseaseJordan Schultz · completed · Parkinson Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Dorsomedial Striatal Dopamine and Dementia in Parkinson's DiseaseR01NS144085 · NINDS · UNIVERSITY OF IOWA · fiscal years 2026 · $597,466 awarded in 2026Same name and institution; not confirmed by an ID
- Frontal midline delta/theta rhythms and cognitive control in PDR01NS100849 · NINDS · UNIVERSITY OF IOWA · fiscal years 2017 to 2026 · $700,136 awarded in 2026Same name and institution; not confirmed by an ID
- Linear predictive coding of EEG Activity for Diagnosis of Parkinson's Disease (LEAD-PD)R01NS127809 · NINDS · UNIVERSITY OF IOWA · fiscal years 2026 · $625,577 awarded in 2026Same name and institution; not confirmed by an ID
- VTA dopamine neurons and cognitive symptoms of Parkinson’s diseaseR01NS120987 · NINDS · UNIVERSITY OF IOWA · fiscal years 2021 to 2025 · $271,538 awarded in 2025Same name and institution; not confirmed by an ID
- Linear predictive coding of EEG Activity for Diagnosis of Parkinson's Disease (LEAD-PD)RF1NS127809 · NINDS · UNIVERSITY OF IOWA · fiscal years 2023 · $1,876,731 awarded in 2023Same name and institution; not confirmed by an ID
- Prefrontal Cortex, Cognition, and Speech Symptoms in PD (PRECIS-PD)P20NS123151 · NINDS · UNIVERSITY OF IOWA · fiscal years 2021 to 2022 · $426,631 awarded in 2022Same name and institution; not confirmed by an ID
- Timing and dopamine in frontostriatal circuitsR01MH116043 · NIMH · UNIVERSITY OF IOWA · fiscal years 2018 to 2022 · $481,790 awarded in 2022Same name and institution; not confirmed by an ID
- Prefrontal D1 signaling and cognitive symptoms of Parkinson's diseaseR01NS089470 · NINDS · UNIVERSITY OF IOWA · fiscal years 2014 to 2018 · $295,675 awarded in 2018Same name and institution; not confirmed by an ID
- Prefrontal dopamine and cognitive symptoms of Parkinsons diseaseK08NS078100 · NINDS · UNIVERSITY OF IOWA · fiscal years 2012 to 2016 · $179,788 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:01 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.Phytother Res · 201985 citationsRCR 5.9
- 44 citationsRCR 3.4
- A pilot to assess target engagement of terazosin in Parkinson's disease.Parkinsonism Relat Disord · 202240 citationsRCR 3.3
- 10 citationsRCR 0.6